23andMe Angles For A Bigger Regeneron Bid As Ex-CEO Steps Up With A Better Offer

investors.com/news/technology/23andme-former-ceo-anne-wojcicki-regeneron-pharmaceuticals

23andMe wants to reopen bidding on its assets after former CEO Anne Wojcicki put together a $305 million offer, topping Regeneron.
The post 23andMe Angles For A Bigger Regeneron Bid As Ex-CEO Steps Up With A Better Offer appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-05 14:17:16.
The Entire Business World on a Single Page. Free to Use →